MedPath

Is it Possible to Screen for Type 2 Diabetes at Day 2 in Gestational Diabetes Mellitus Patients Postpartum?

Completed
Conditions
Gestational Diabetes Mellitus
Type 2 Diabetes
Interventions
Procedure: Oral glucose tolerance test
Registration Number
NCT00921882
Lead Sponsor
Université de Sherbrooke
Brief Summary

Within 6 months of delivery, women who had gestational diabetes mellitus should be screened for type 2 diabetes with a fasting plasma glucose test and/or a 2-h postchallenge glycemia in a 75-g oral glucose tolerance test. However, not all women are screened. The objective of this study is to compare the screening test for type 2 diabetes done at 48 hours post-partum versus 8 weeks post-partum. The investigators want to measure the specificity, sensitivity, false and true predictive values of the screening test at 48 hours post-partum compared to the gold-standard.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
51
Inclusion Criteria
  • Dx of gestational diabetes treated with insulin
  • To be in post-partum
  • Delivery of a baby of at least 37 weeks of gestation
  • Have signed the consent form
Exclusion Criteria
  • History of glucose intolerance of diabetes before the pregnancy
  • Obstetrical pathology during pregnancy

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Oral glucose tolerance testOral glucose tolerance testoral glucose tolerance test performed 48 hours post-partum and 8 weeks post-partum.
Primary Outcome Measures
NameTimeMethod
Oral glucose tolerance test8 weeks post partum

Sensitivity, specificity, true and false predictive values of the oral glucose tolerance test

Secondary Outcome Measures
NameTimeMethod
Acceptability of screening test8 weeks post partum

Prefered moment to do the screening test (48 hours post partum or 8 weeks post partum)

Trial Locations

Locations (1)

Centre hospitalier universitaire de Sherbrooke

🇨🇦

Sherbrooke, Quebec, Canada

© Copyright 2025. All Rights Reserved by MedPath